Effects of repetitive transcranial magnetic stimulation to supplementary motor area and primary motor cortex on motor performances in people with Parkinson disease
- Conditions
- The participant in this study is people with Parkinson disease.Brain stimulationBradykinesiaCoordinationParkinson diseaseReach-to-grasp performance
- Registration Number
- TCTR20230118001
- Lead Sponsor
- Research Grant for New Scholar supported by National Research Council of Thailand (NRCT)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 40
1 age range from 40 to 80 years
2 mild to moderate severity with Hoehn and Yahr H&Y stages 1 to 3
3 more impaired on the right hand dominant as examined by the Unified Parkinson Disease Rating Scale part III
4 On medication during practicing and testing in this study
5 ability to understand and follow simple commands with greater than 23 on the Mini mental state examination Thai version 2002
6 Have normal or corrected to normal vision and normal hearing and
7 ability to sit independently for more than one hour
1.contraindication for TMS confirmed by TMS screening questionnaire
2.severe action or resting tremor
3. severe rigidity
4. ON/OFF medication fluctuations
5. severe disability from dyskinesia
6. Diagnosed with secondary parkinsonism
7. other neurological and/or musculoskeletal problems
8.implanted deep brain stimulation (DBS) or plan to have DBS during the study period
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Behavioral outcomes Baseline and post intervention The Behavioral outcomes will be represented by reach-to-grasp actions that will be measured by the motion monitor tracking systems. This will be showed by the kinematic data such as movement time(ms).
- Secondary Outcome Measures
Name Time Method Cortical outcomes Baseline and Post intervention Cortical outcomes will be represented by corticomotor excitability (MEP) and cortical inhibition (CSP) that will be measured by a single-pulse TMS.